Klingman & Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$738K Buy
2,097
+71
+4% +$25.3K 0.04% 162
2025
Q4
$663K Buy
2,026
+99
+5% +$31.4K 0.03% 164
2025
Q3
$544K Buy
1,927
+72
+4% +$20.9K 0.03% 181
2025
Q2
$518K Buy
1,855
+505
+37% +$143K 0.03% 170
2025
Q1
$421K Buy
1,350
+164
+14% +$48.4K 0.03% 176
2024
Q4
$309K Sell
1,186
-12
-1% -$3.56K 0.02% 203
2024
Q3
$386K Buy
1,198
+2
+0.2% +$654 0.02% 185
2024
Q2
$374K Sell
1,196
-52
-4% -$15.3K 0.03% 170
2024
Q1
$355K Buy
1,248
+63
+5% +$18.4K 0.02% 179
2023
Q4
$341K Buy
1,185
+12
+1% +$3.27K 0.03% 173
2023
Q3
$315K Sell
1,173
-27
-2% -$6.74K 0.03% 173
2023
Q2
$266K Buy
1,200
+263
+28% +$61K 0.02% 182
2023
Q1
$227K Buy
937
+56
+6% +$13.7K 0.02% 183
2022
Q4
$231K Sell
881
-42
-5% -$11.3K 0.02% 183
2022
Q3
$208K Buy
923
+20
+2% +$4.85K 0.02% 179
2022
Q2
$220K Sell
903
-2
-0.2% -$490 0.02% 179
2022
Q1
$218K Sell
905
-494
-35% -$114K 0.02% 190
2021
Q4
$315K Buy
1,399
+255
+22% +$53.8K 0.03% 141
2021
Q3
$243K Hold
1,144
0.02% 153
2021
Q2
$279K Hold
1,144
0.03% 135
2021
Q1
$285K Buy
1,144
+15
+1% +$3.58K 0.03% 137
2020
Q4
$260K Sell
1,129
-7
-0.6% -$1.61K 0.03% 132
2020
Q3
$289K Buy
+1,136
New +$281K 0.04% 112
2016
Q1
Sell
-1,000
Closed -$162K 382
2015
Q4
$162K Buy
+1,000
New +$157K 0.06% 123

Other funds holding AMGN

Klingman & Associates's AMGN Position: Q1 2026 in Review

Klingman & Associates increased its Amgen (AMGN) stake by 3.5% in Q1 2026, buying an estimated $25.3K and bringing the position to 2,097 shares worth $738K. The position accounts for 0.04% of the portfolio, ranked #162.

Klingman & Associates first reported a position in AMGN in Q4 2015 and has held it in 24 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Klingman & Associates held 2,097 shares of Amgen worth $738K as of Q1 2026.
  • Klingman & Associates bought 71 Amgen shares in Q1 2026, an estimated $25.3K.
  • Amgen made up 0.04% of Klingman & Associates's portfolio in Q1 2026, its #162 holding.
  • Klingman & Associates first reported a position in Amgen in Q4 2015 and has held it in 24 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Klingman & Associates's 13F filing for Q1 2026, filed 14 May 2026.